BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 15634899)

  • 1. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation.
    Baelder R; Fuchs B; Bautsch W; Zwirner J; Köhl J; Hoymann HG; Glaab T; Erpenbeck V; Krug N; Braun A
    J Immunol; 2005 Jan; 174(2):783-9. PubMed ID: 15634899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy.
    Drouin SM; Corry DB; Hollman TJ; Kildsgaard J; Wetsel RA
    J Immunol; 2002 Nov; 169(10):5926-33. PubMed ID: 12421977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma.
    Köhl J; Baelder R; Lewkowich IP; Pandey MK; Hawlisch H; Wang L; Best J; Herman NS; Sproles AA; Zwirner J; Whitsett JA; Gerard C; Sfyroera G; Lambris JD; Wills-Karp M
    J Clin Invest; 2006 Mar; 116(3):783-96. PubMed ID: 16511606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with the C5a receptor/CD88 antagonist PMX205 reduces inflammation in a murine model of allergic asthma.
    Staab EB; Sanderson SD; Wells SM; Poole JA
    Int Immunopharmacol; 2014 Aug; 21(2):293-300. PubMed ID: 24859057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3a-induced IL-17 plays a critical role in an IgE-mediated late-phase asthmatic response and airway hyperresponsiveness via neutrophilic inflammation in mice.
    Mizutani N; Goshima H; Nabe T; Yoshino S
    J Immunol; 2012 Jun; 188(11):5694-705. PubMed ID: 22539791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.
    Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J
    J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
    Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
    J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in rat and murine models of lung inflammation.
    Tschernig T; Kiafard Z; Dibbert C; Neumann D; Zwirner J
    Exp Toxicol Pathol; 2007 Aug; 58(6):419-25. PubMed ID: 17544263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
    Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
    Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.
    Gavett SH; O'Hearn DJ; Li X; Huang SK; Finkelman FD; Wills-Karp M
    J Exp Med; 1995 Nov; 182(5):1527-36. PubMed ID: 7595222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthma.
    Fregonese L; Swan FJ; van Schadewijk A; Dolhnikoff M; Santos MA; Daha MR; Stolk J; Tschernig T; Sterk PJ; Hiemstra PS; Rabe KF; Mauad T
    J Allergy Clin Immunol; 2005 Jun; 115(6):1148-54. PubMed ID: 15940127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant protein D inhibits early airway response in Aspergillus fumigatus-sensitized mice.
    Erpenbeck VJ; Ziegert M; Cavalet-Blanco D; Martin C; Baelder R; Glaab T; Braun A; Steinhilber W; Luettig B; Uhlig S; Hoymann HG; Krug N; Hohlfeld JM
    Clin Exp Allergy; 2006 Jul; 36(7):930-40. PubMed ID: 16839409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desloratadine inhibits allergen-induced airway inflammation and bronchial hyperresponsiveness and alters T-cell responses in murine models of asthma.
    Bryce PJ; Geha R; Oettgen HC
    J Allergy Clin Immunol; 2003 Jul; 112(1):149-58. PubMed ID: 12847492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small interfering RNA against CD86 during allergen challenge blocks experimental allergic asthma.
    Asai-Tajiri Y; Matsumoto K; Fukuyama S; Kan-O K; Nakano T; Tonai K; Ohno T; Azuma M; Inoue H; Nakanishi Y
    Respir Res; 2014 Oct; 15(1):132. PubMed ID: 25344652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vbeta8+ T lymphocytes are essential in the regulation of airway hyperresponsiveness and bronchoalveolar eosinophilia but not in allergen-specific IgE in a murine model of allergic asthma.
    Hofstra CL; Van Ark I; Savelkoul HF; Cruikshank WW; Nijkamp FP; Van Oosterhout AJ
    Clin Exp Allergy; 1998 Dec; 28(12):1571-80. PubMed ID: 10024230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protective role for C5a in the development of allergic asthma associated with altered levels of B7-H1 and B7-DC on plasmacytoid dendritic cells.
    Zhang X; Lewkowich IP; Köhl G; Clark JR; Wills-Karp M; Köhl J
    J Immunol; 2009 Apr; 182(8):5123-30. PubMed ID: 19342693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
    Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
    Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats.
    Abe M; Shibata K; Akatsu H; Shimizu N; Sakata N; Katsuragi T; Okada H
    J Immunol; 2001 Oct; 167(8):4651-60. PubMed ID: 11591795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells without c-Myc reduce airway responsiveness and allergic reaction in sensitized mice.
    Wang CY; Chiou GY; Chien Y; Wu CC; Wu TC; Lo WT; Chen SJ; Chiou SH; Peng HJ; Huang CF
    Transplantation; 2013 Dec; 96(11):958-65. PubMed ID: 23989473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.